Serum Institute of India chief Adar Poonawalla hopes to launch new vaccine Covovax by June 2021

The chief of Serum Institute of India Adar Poonawalla announced that the company is looking forward to launch a second coronavirus vaccine, which if approved, could be India's third COVID-19 vaccine. Covishield has been developed by SII in partnership with the Oxford University and British-Swedish firm AstraZeneca.